Virtus Fund Advisers’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-789
| Closed | -$65.9K | – | 120 |
|
|
2023
Q4 | $65.9K | Hold |
789
| – | – | 0.41% | 35 |
|
|
2023
Q3 | $23.2K | Buy |
789
+239
| +43% | +$7.04K | 0.16% | 91 |
|
|
2023
Q2 | $17.9K | Hold |
550
| – | – | 0.13% | 97 |
|
|
2023
Q1 | $19.4K | Sell |
550
-373
| -40% | -$13.1K | 0.14% | 101 |
|
|
2022
Q4 | $42.3K | Buy |
+923
| New | +$42.3K | 0.3% | 64 |
|
|
2017
Q4 | $348K | Buy |
+42,645
| New | +$348K | ﹤0.01% | 408 |
|
|
2014
Q3 | – | Sell |
-2,952
| Closed | -$14K | – | 1343 |
|
|
2014
Q2 | $14K | Buy |
+2,952
| New | +$14K | ﹤0.01% | 2626 |
|